Skip to content
healthcare.dev
Get a free key

DAPAGLIFLOZIN

NDC 70377-023, DAPAGLIFLOZIN, tablet, film coated, from Biocon Pharma Inc..

Product NDC
70377-023
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211470
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70377-023-117037700231130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-023-11)
70377-023-12703770023121000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-023-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/828f1004-3647-9a13-8008-c4b3759ecfd0

Use it

Look up 70377-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.